Local, national & international business news and events.
LAWRENCEVILLE, N.J.–(BUSINESS WIRE)–Asana BioSciences, a clinical stage biopharmaceutical company, announced that ASN007 clinical data on safety, efficacy and pharmacokinetics in solid tumor patients will be presented at the 32nd EORTC-NCI-AACR Virtual Symposium on Molecular Targets and Cancer Therapeutics (ENA 2020) to be
Tesla on Wednesday is expected to report a profit for the fifth consecutive quarter, putting it on track to report its only annual profit since its founding in 2003. But the company will also face questions about whether the strong sales growth
Data from More Than 50 Clinical and Epidemiological Abstracts Across Vaccines, HIV, Antibiotics and Antimicrobials Show the Breadth of the Company’s Commitment to Addressing the Threat of Infectious Diseases KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside the United States
In a statement, the magazine said it was investigating a matter involving the author and CNN legal analyst. — New York Times: Top Stories
CHATHAM, N.J.–(BUSINESS WIRE)–Retail investing hit several new highs for account openings, number of trades, and volume traded in Q3 amid the ongoing global economic uncertainty due to the pandemic, according to new data released today by DriveWealth, a leader in global digital
NEW YORK & CRANBURY, N.J.–(BUSINESS WIRE)–Onyx Enterprises Int’l, Corp. (“Onyx”), owner and operator of a leading digital commerce platform for the automotive market, “CARiD.com,” which has entered into a definitive business combination agreement with Legacy Acquisition Corp. (NYSE: “LGC”) (“Legacy”), a publicly-traded
OPTIMIZE Pivotal Study 1 Year Outcomes Announced at TCT Connect NEW PROVIDENCE, N.J.–(BUSINESS WIRE)–The Svelte® Drug-Eluting Stent (DES) achieved 1.5% clinically-driven Target Lesion Revascularization (TLR) at 1 year, the lowest ever reported in an Investigational Device Exemption (IDE) clinical study. Primary and
PRINCETON, N.J.–(BUSINESS WIRE)–$NRG #earnings–NRG Energy, Inc. (NYSE:NRG) plans to report Third Quarter 2020 financial results on Thursday, November 5, 2020. Management will present the results during a conference call and webcast at 9:00 a.m. Eastern. A live webcast of the conference call,
Application based on Phase 3 ATTRACTION-3 trial demonstrating a statistically significant and clinically meaningful improvement in patients’ overall survival compared to chemotherapy PRINCETON, N.J.–(BUSINESS WIRE)–$BMY #ATTRACTION3—Bristol Myers Squibb (NYSE:BMY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of